 "Alkem labs, Alkem logo")
SBI Mutual Fund on Friday bought additional shares of pharmaceutical company Alkem Laboratories for Rs 300 crore through an open market transaction.
According to the block deal data available on the National Stock Exchange (NSE), SBI Mutual Fund acquired 6.41 lakh shares or 0.54 per cent stake in Mumbai-headquartered Alkem Laboratories.
The shares were picked up at an average price of Rs 4,680 apiece, taking the transaction value to Rs 300.32 crore.
After the stake buy, SBI Mutual Fund's holding in Alkem rose to 2.7 per cent from 2.16 per cent.
Meanwhile, Samprada & Nanhamati Singh Family Trust (related to Alkem promoters) offloaded the same number of shares of the company, showed the data on the NSE.
On Friday, shares of Alkem Laboratories fell 2.54 per cent to close at Rs 4,600.05 apiece on the NSE.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
 "FPI, Rupee, foreign portfolio investors")
 "Indian equities continue their upward trajectory but largecaps, those stocks valued at Rs 20,000 crore or more, continue to underperform the broader market. The largecap-oriented BSE Sensex is up 31.9 per cent since the end of October last year laggi")
 "Madhabi Puri Buch, Chairperson of the Securities and Exchange Board of India during a Launch of three key Mutual Fund industry in Mumbai on Friday, February 21, 2025 – Photo: KAMLESH PEDNEKAR")
 "Zomato")
 "metal")
